omega-n-methylarginine has been researched along with Sepsis in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 19 (55.88) | 18.2507 |
2000's | 11 (32.35) | 29.6817 |
2010's | 4 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmetaj-Shala, B; Gashaw, H; Gray, N; Kirkby, NS; Leiper, JM; MacCallum, N; Mitchell, JA; Mumby, S; Paul-Clark, M; Quinlan, GJ; Tesfai, A; Want, E | 1 |
Hobbs, AJ; Sand, CA | 1 |
Matejovic, M; Radermacher, P; Stahl, W | 1 |
Takala, J | 1 |
Evans, TW; Mitchell, JA; Price, S | 1 |
Bose, D; Bose, R; Cheng, ZQ; Duke, K; Jacobs, H; Light, RB; Mink, SN; Roberts, DE | 1 |
Mayr, FB; Spiel, AO | 1 |
Ning, J; Titheradge, MA; Wallington, J | 1 |
Bose, R; Cheng, ZQ; Jacobs, H; Kasian, K; Light, RB; Mink, SN; Santos Martinez, LE | 1 |
Cheng, W; Cunningham, JN; Damiani, P; Henderson, JL; Horovitz, JH; Siconolfi, A; Statman, R | 1 |
Caveda, L; Moncada, S; Padrón, J; Palacios, M; Rojas, A | 1 |
Booke, M; Hinder, F; McGuire, R; Traber, DL; Traber, LD | 3 |
Dehring, DJ; Ehardt, JS; Lingnau, W; Nelson, SH; Traber, D; Traber, L | 1 |
Hollenberg, SM; Parrillo, JE; Piotrowski, MJ | 1 |
Buttery, LK; Cohen, J; Evans, TJ; Moyes, D; Polak, J; Sriskandan, S; Wilkinson, J | 1 |
Easington, C; Hollenberg, SM; Parrillo, JE; Piotrowski, MJ; Tangora, JJ | 1 |
Giercksky, KE; Kirkebøen, KA; Strand, OA | 1 |
Bone, HG; Deyo, DJ; Fischer, SR; McGuire, R; Traber, DL; Traber, LD | 1 |
Ceppi, ED; Smith, FS; Titheradge, MA | 1 |
Hollenberg, SM | 1 |
Bacher, JD; Banks, SM; Danner, RL; Eichacker, PQ; Freeman, BD; Garvey, EP; Jurgensen, CH; Natanson, C; Tuttle, JV; Zeni, F | 1 |
Fujii, S; Numagami, Y; Suzuki, Y; Tominaga, T; Yoshimoto, T; Yoshimura, T | 1 |
Comtois, A; Ebihara, S; El Dwairi, Q; Gottfried, SB; Hussain, SN; Lin, MC; Petrof, BJ; Yang, L | 1 |
Ekin, S; Evora, PR; Pearson, PJ; Schaff, HV | 1 |
Lew, WY; Yasuda, S | 1 |
Balk, RA; Symeonides, S | 1 |
Broussard, M; Easington, CR; Hollenberg, SM; Osman, J; Parrillo, JE | 1 |
Doherty, JC; McMillen, MA | 1 |
Easington, CR; Hollenberg, SM; Mattoo, A; Parrillo, JE; Sundrani, R | 1 |
Chan, N; Vallance, P | 1 |
Beach, PK; Garrison, RN; Harris, PD; Kawabe, T; Spain, DA | 1 |
Gabbai, FB | 1 |
6 review(s) available for omega-n-methylarginine and Sepsis
Article | Year |
---|---|
The nuances of NO synthase regulation in sepsis: Could targeting BH4 be the answer?
Topics: Animals; Biopterins; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypotension; Nitric Oxide Synthase; omega-N-Methylarginine; Sepsis | 2016 |
Should we target blood pressure in sepsis?
Topics: Blood Pressure; Hemodynamics; Humans; Hypertension; omega-N-Methylarginine; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Sepsis; Vasoconstrictor Agents | 2010 |
Nitric oxide, sepsis and liver metabolism.
Topics: Animals; Cytokines; Gluconeogenesis; Glucose; Humans; Liver; Liver Glycogen; Nitric Oxide; omega-N-Methylarginine; Postoperative Complications; Reactive Oxygen Species; Sepsis; Shock, Septic | 1997 |
Nitric oxide in the pathogenesis of sepsis.
Topics: Animals; Cardiovascular System; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Sepsis; Shock, Septic | 1999 |
Endothelial function and nitric oxide: clinical relevance.
Topics: Arginine; Cardiovascular Diseases; Coronary Disease; Endothelium, Vascular; Genetic Therapy; Humans; Nitric Oxide; omega-N-Methylarginine; Risk Factors; Sepsis; Vasoconstriction | 2001 |
Effects of nitric oxide synthase blockers on renal function.
Topics: Animals; Hemodynamics; Humans; Kidney; Nephritis, Interstitial; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Renal Circulation; Sepsis | 2001 |
28 other study(ies) available for omega-n-methylarginine and Sepsis
Article | Year |
---|---|
Metabolomic profiling of amines in sepsis predicts changes in NOS canonical pathways.
Topics: Adult; Aged; Amines; Animals; Arginine; Cell Line; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mass Spectrometry; Metabolomics; Mice; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Sepsis | 2017 |
Inhibition of nitric oxide synthase during sepsis: revival because of isoform selectivity?
Topics: Acidosis; Animals; Blood Circulation; Clinical Trials, Phase II as Topic; Early Termination of Clinical Trials; Endotoxemia; Fluid Therapy; Humans; Imidazoles; Mice; Mice, Knockout; Molsidomine; Nitric Oxide Synthase Type II; Norepinephrine; omega-N-Methylarginine; Protein Isoforms; Pyridines; Sepsis; Shock, Septic; Swine | 2010 |
Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shock.
Topics: Animals; Atrial Natriuretic Factor; Cell Death; Electric Stimulation; Enzyme Inhibitors; Heart; Heart Atria; L-Lactate Dehydrogenase; Lipopolysaccharides; Male; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organ Culture Techniques; Rats; Salmonella enteritidis; Sepsis; Shock, Septic | 2002 |
Lysozyme binding to endocardial endothelium mediates myocardial depression by the nitric oxide guanosine 3',5' monophosphate pathway in sepsis.
Topics: Animals; Cell Membrane; Cyclic GMP; Dogs; Endocardium; Endothelium; In Vitro Techniques; Muramidase; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Quinoxalines; Sepsis | 2005 |
NO-synthase inhibition in sepsis.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Humans; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Sepsis; Shock, Septic | 2006 |
The control of hepatic glycogen metabolism in an in vitro model of sepsis.
Topics: Adenylate Kinase; Animals; Cytokines; Disease Models, Animal; Glucose; Glucose-6-Phosphate; Glycogen Phosphorylase; Glycogen Synthase; Glycogen Synthase Kinase 3; Glycogenolysis; Humans; Lactic Acid; Lipopolysaccharides; Liver; Liver Glycogen; Male; omega-N-Methylarginine; Phosphorylation; Protein Kinases; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Sepsis; Uridine Diphosphate Glucose | 2008 |
Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation.
Topics: Aminoquinolines; Animals; Carotid Artery, Internal; Catalase; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Free Radical Scavengers; Guanylate Cyclase; Humans; Hydrogen Peroxide; Hydroquinones; In Vitro Techniques; Indomethacin; Mannitol; Mesenteric Artery, Superior; Methylene Blue; Muramidase; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxadiazoles; Phenylephrine; Prostaglandins; Protein Kinase Inhibitors; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sepsis; Signal Transduction; Soluble Guanylyl Cyclase; Thionucleotides; Time Factors; Vasoconstrictor Agents; Vasodilation | 2008 |
The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Bacteremia; Blood Gas Analysis; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Escherichia coli Infections; Hemodynamics; NADPH Dehydrogenase; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Sepsis | 1994 |
Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharide.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; omega-N-Methylarginine; Sepsis; Tumor Necrosis Factor-alpha | 1993 |
Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep.
Topics: Animals; Arginine; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Hemodynamics; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Oxygen Consumption; Prospective Studies; Sepsis; Sheep; Time Factors; Vasoconstrictor Agents | 1996 |
Differential effects of prolonged septicemia on isolated pulmonary arteries and veins from sheep.
Topics: ADP Ribose Transferases; Animals; Bacterial Toxins; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Exotoxins; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Pulmonary Artery; Pulmonary Veins; Sepsis; Sheep; Virulence Factors | 1996 |
Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats.
Topics: Animals; Arterioles; Cecum; Dose-Response Relationship, Drug; Endothelin-1; Male; Microscopy, Video; Muscle, Skeletal; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Reference Values; Sepsis; Vasoconstriction; Vasodilation | 1997 |
The role of nitric oxide in experimental murine sepsis due to pyrogenic exotoxin A-producing Streptococcus pyogenes.
Topics: Animals; Cells, Cultured; Exotoxins; Immunohistochemistry; Interferon-gamma; Kidney; Kupffer Cells; Liver; Macrophages, Peritoneal; Male; Mice; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Recombinant Proteins; Sepsis; Streptococcal Infections; Streptococcus pyogenes | 1997 |
Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: effects on regional blood flow.
Topics: Animals; Enzyme Inhibitors; Kidney; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Pancreas; Pseudomonas aeruginosa; Regional Blood Flow; Sepsis; Sheep; Vasoconstrictor Agents | 1996 |
Impaired microvascular vasoconstrictive responses to vasopressin in septic rats.
Topics: Animals; Arterioles; Enzyme Inhibitors; Ligation; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Sepsis; Vasoconstriction; Vasoconstrictor Agents; Vasopressins | 1997 |
Inhibition of nitric oxide synthase does not affect survival in a rat model of abdominal sepsis.
Topics: Animals; beta-Aminoethyl Isothiourea; Cecum; Enzyme Inhibitors; Intestinal Perforation; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Wistar; Sepsis | 1997 |
Nitric oxide synthase inhibition restores hypoxic pulmonary vasoconstriction in sepsis.
Topics: Animals; Constriction, Pathologic; Disease Models, Animal; Female; Hemodynamics; Hypoxia; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pseudomonas Infections; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Sepsis; Sheep; Ultrasonography | 1997 |
A yellow light for nitric oxide synthase inhibitors in sepsis: proceed with caution.
Topics: Animals; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Sepsis | 1998 |
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines.
Topics: Animals; Dogs; Drug Combinations; Enzyme Inhibitors; Epinephrine; Escherichia coli Infections; Hemodynamics; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Sepsis; Vasoconstrictor Agents | 1998 |
In vivo nitric oxide detection in the septic rat brain by electron paramagnetic resonance.
Topics: Animals; Brain; Brain Diseases; Chelating Agents; Ditiocarb; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Escherichia coli; Female; Iron; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Sepsis; Spin Trapping | 1998 |
Diaphragm sarcolemmal injury is induced by sepsis and alleviated by nitric oxide synthase inhibition.
Topics: Animals; Blotting, Western; Cecal Diseases; Cell Membrane Permeability; Coloring Agents; Diaphragm; Disease Models, Animal; Endotoxins; Enzyme Inhibitors; Escherichia coli; Intestinal Perforation; Lipopolysaccharides; Male; Membrane Potentials; Muscle Contraction; Muscle Fibers, Skeletal; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peritonitis; Rats; Rats, Sprague-Dawley; Sarcolemma; Sepsis | 1998 |
Endothelium-dependent vasodilation in response to Pseudomonas aeruginosa lipopolysaccharide: an in vitro study on canine arteries.
Topics: Animals; Coronary Vessels; Dogs; Enzyme Inhibitors; Female; Hypotension; In Vitro Techniques; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pseudomonas aeruginosa; Sepsis; Vasodilation; Vasodilator Agents | 1998 |
Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Calcium; Cells, Cultured; Chelating Agents; Cyclic GMP; Enzyme Inhibitors; Female; Heart Ventricles; Imidazoles; Indoles; Lipopolysaccharides; Losartan; Male; Mitochondria; Muscle Fibers, Skeletal; Myocardial Contraction; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rabbits; Receptors, Angiotensin; Sepsis; Ventricular Function | 1999 |
Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice.
Topics: Animals; Drug Evaluation, Preclinical; Enzyme Inhibitors; Isothiuronium; Male; Mice; Mice, Inbred BALB C; Microcirculation; Microscopy, Video; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Norepinephrine; omega-N-Methylarginine; Sepsis | 1999 |
Noradrenaline and nomega-monomethyl-L-arginine (L-NMMA): effects on haemodynamics and regional blood flow in healthy and septic sheep.
Topics: Animals; Blood Pressure; Female; Hemodynamics; Norepinephrine; omega-N-Methylarginine; Oxygen; Prospective Studies; Pseudomonas aeruginosa; Regional Blood Flow; Sepsis; Sheep; Vasoconstriction | 2000 |
Use of animal models to test novel therapies in sepsis.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; omega-N-Methylarginine; Sepsis; Swine | 2000 |
Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats.
Topics: Animals; Cell Adhesion; Enzyme Inhibitors; Leukocytes; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Prospective Studies; Rats; Sepsis; Venules | 2000 |
Sepsis increases NOS-2 activity and decreases non-NOS-mediated acetylcholine-induced dilation in rat aorta.
Topics: Acetylcholine; Animals; Aorta; Enzyme Inhibitors; In Vitro Techniques; Lysine; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Sepsis; Vasodilation; Vasodilator Agents | 2001 |